![Chris Mirabelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Mirabelli
Président chez
Flamingo Therapeutics BV
Fortune : 148 934 $ au 31/05/2026
Profil
Chris K.
Mirabelli is the founder of Ionis Pharmaceuticals, Inc., founded in 1989, where the title held was Senior Vice President-Research from 1989 to 1993.
Current jobs include Executive Chairman at Flamingo Therapeutics BV; Director at Theraclone Sciences, Inc., Galleon Pharmaceuticals, Inc., Visionary Therapeutics Corp., Fredonia College Foundation, and Guilford College (Trustee); Managing Director at Healthcare Partners VIII LLC, HealthCare Ventures LLC (since 2000), Healthcare Partners IX LLC, and Healthcare Strategic Partners, LLC; and Independent Director at Aro Biotherapeutics Co. (since 2020).
Former jobs include Chairman, President & Chief Executive Officer at LeukoSite, Inc. (1993–1999); Chief Executive Officer & Director at Anexon, Inc. (2012–2014); Chairman at Thios Pharmaceuticals, Inc. and Proteostasis Therapeutics, Inc. (2010–2016);.
Director, President-Pharmaceutical R&D at Millennium Pharmaceuticals, Inc. (1999–2000); Director at Critical Therapeutics, Inc. (2001–2008), FoldRx Pharmaceuticals LLC, Anchor Therapeutics, Inc., Antisoma, Inc., and Cypherpunk Technologies, Inc. (2025–2026); Independent Director at Trevena, Inc. (2013–2014); President & Director at DecImmune Therapeutics, Inc.; President at Adheron Therapeutics, Inc.; Principal at SmithKline & French SpA; and Member-Supervisory Board at Dynacure SA. Education includes an undergraduate degree from The State University of New York College at Fredonia in 1977 and a doctorate from Baylor College of Medicine in 1981.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 131 800 ( 0,12 % ) | 148 934 $ | 31/05/2026 |
Postes actifs de Chris Mirabelli
| Sociétés | Poste | Début |
|---|---|---|
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Private Equity Investor | 01/01/2000 |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Directeur/Membre du Conseil | - |
Visionary Therapeutics Corp.
 Visionary Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops ocular therapeutics for eye diseases | Directeur/Membre du Conseil | 07/08/2009 |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for breathing-control conditions | Directeur/Membre du Conseil | - |
Healthcare Partners VIII LLC | Corporate Officer/Principal | - |
Guilford College
 Guilford College Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Healthcare Partners IX LLC | Corporate Officer/Principal | - |
Healthcare Strategic Partners, LLC
 Healthcare Strategic Partners, LLC Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | - |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Directeur/Membre du Conseil | 13/10/2020 |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Chris Mirabelli
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Chris Mirabelli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Health Technology |
Thios Pharmaceuticals, Inc.
 Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes proprietary therapies that target biological sulfation | Health Technology |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Health Technology |
Adheron Therapeutics, Inc.
 Adheron Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
DecImmune Therapeutics, Inc.
 DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation | Health Technology |
Galleon Pharmaceuticals, Inc.
Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for breathing-control conditions | Health Technology |
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Health Technology |
Healthcare Partners VIII LLC | |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Finance |
SmithKline & French SpA
 SmithKline & French SpA Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceuticals | Health Technology |
The State University of New York College at Fredonia
 The State University of New York College at Fredonia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guilford College
Guilford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Visionary Therapeutics Corp.
Visionary Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops ocular therapeutics for eye diseases | Health Technology |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Anexon, Inc.
 Anexon, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cardiovascular diseases | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
Healthcare Partners IX LLC | |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
Healthcare Strategic Partners, LLC
Healthcare Strategic Partners, LLC Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Health Technology |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
Fredonia College Foundation
 Fredonia College Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a fund raising organization | Commercial Services |
Choisissez Zonebourse 
